- Investigator
- Thomas J George
Clinical trials
-
Sorafenib Plus Capecitabine(SORCAPE) in Previously Treated Metastatic Colorectal Cancer -
A Phase II Platform Study to Evaluate Treatment in Patients with Colorectal Cancer The NSABP FC-13 study is being done to determine if using immunotherapies alone or in combination with other drugs will delay or prevent colorectal cancer from coming back in patients with colorectal cancer who are ctDNA-positive after their…
- Investigator
- Thomas J George
- Ages
- 18 Years - N/A
- Sexes
- All
-
BLUE-C The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test.
- Ages
- 40 Years - N/A
- Sexes
- All
-
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy for Limited mCRC(ERASur) This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients…
- Investigator
- Kathryn E Hitchcock
- Ages
- 18 Years - N/A
- Sexes
- All